Atıf Formatları
Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Bahadir Et Al. , "Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients," JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.15, no.1, pp.26-31, 2019

Bahadir, A. Et Al. 2019. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.15, no.1 , 26-31.

Bahadir, A., Eral, G., Budak, M., Shimamoto, F., Korpinar, M. A., Erdamar, S., ... Tuncel, H.(2019). Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.15, no.1, 26-31.

Bahadir, Anzel Et Al. "Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients," JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.15, no.1, 26-31, 2019

Bahadir, Anzel Et Al. "Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.15, no.1, pp.26-31, 2019

Bahadir, A. Et Al. (2019) . "Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.15, no.1, pp.26-31.

@article{article, author={Anzel Bahadir Et Al. }, title={Association of clinicopathological features with E-cadherin (CDH1) gene-160 C > A promoter polymorphism in Turkish colorectal cancer patients}, journal={JOURNAL OF CANCER RESEARCH AND THERAPEUTICS}, year=2019, pages={26-31} }